Allergen Immunotherapy

  • Roger W. Fox
  • Richard F. Lockey
Part of the Current Clinical Practice book series (CCP)


Allergen immunotherapy results in decreased sensitivity to allergens, observed clinically and demonstrated by laboratory techniques, in response to the gradual administration of increasing doses of allergenic extracts. Allergen immunotherapy is used to treat allergic rhinitis (hay fever), allergic asthma, and insect hypersensitivity. During the first half of the century, efficacy of allergen immunotherapy was based primarily on clinical observations. However, over the past 40 years, the fascinating, scientific investigations of allergens and of the immunologic complexities of the allergic reaction have improved our understanding of immunotherapy with allergens, such as pollens, molds, animal danders, house dust mites, and insect venoms. Allergen extract injections affect the immunologic response both systemically and at the mucosal membrane surface of the nose and bronchi. This chapter will address the subject of allergen immunotherapy for allergic rhinitis and/or allergic asthma. Immunotherapy for insect hypersensitivity is reviewed in Chapter 6.


Allergic Rhinitis Pollen Season Allergic Asthma Grass Pollen House Dust Mite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969–974.PubMedGoogle Scholar
  2. Bousquet J, Michel FB. Specific immunotherapy in asthma: Is it effective? J Allergy Clin Immunol 1994; 94: 1–11.PubMedCrossRefGoogle Scholar
  3. Bousquet J, Michel FB. Specific immunotherapy in allergic rhinitis and asthma. In: Busse WW, Holgate ST, eds. Rhinitis and Asthma, Boston: Blackwell Scientific 1994, pp. 1309–1324.Google Scholar
  4. Bush RK, Ritter MW. Allergen immunotherapy for the allergic patient. Immunol Allergy Clin North Am 1992; 12 (1): 107–124.Google Scholar
  5. Cooke RA. Hay fever and asthma. The uses and limitations of desensitization. NY State J. Med. 1918; 107: 577.Google Scholar
  6. Creticos PS, Reed CE, Norman PS and subcenter investigators of the NIAID study. The NIAID cooperative study of the role of immunotherapy in seasonal ragweed-induced adult asthma. J Allergy Clin Immunol 1993; 91: 226.Google Scholar
  7. Dunbar WE The present state our knowledge of hay fever. J. Hygiene 1913; 13: 105.CrossRefGoogle Scholar
  8. Fox RW, Lockey RF. Role of immunotherapy in asthma. In: Gershwin ME, Halpem GM, eds. Bronchial Asthma. Principles of Diagnosis and Treatment, 3rd ed. Totowa, NJ: Humana, 1994; pp. 365–398.Google Scholar
  9. Freeman J. Vaccination against hay fever. Report of results during the last three years. Lancet 1914; 1: 178.Google Scholar
  10. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987; 79: 660–677.Google Scholar
  11. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572.CrossRefGoogle Scholar
  12. Ohman JL Jr. Clinical and immunologic responses to immunotherapy, In: Lockey RF, Bukantz SC, eds. Allergen Immunotherapy, New York; eds. 1991; pp. 209–232.Google Scholar
  13. Platts-Mills TAE, Chapman MD. Allergen standardization. J. Allergy Clin Immunol 1991; 87: 621–624.PubMedCrossRefGoogle Scholar
  14. Van Metre TE, Adkinson NF. Immunotherapy for Aeroallergen Disease. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW. eds. Allergy Principles and Practices, 4th ed. Mosby, Baltimore; 1993, pp. 1489–1506.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Roger W. Fox
  • Richard F. Lockey

There are no affiliations available

Personalised recommendations